Fewer additional medications are needed for hypertension patients who undergo RDN
James Stephen Jenkins, MDJAMA Cardiology - November 9, 2022
PMID: 36350593
James Stephen Jenkins, MD, is a contributing author to an article in JAMA Cardiology covering a 6-month data analysis of the international RADIANCE-HTN TRIO clinical trial.
Connecting Unhealthy Lifestyles to COVID-19 Deaths
Carl J. Lavie, MDThe American Journal of Medicine - November 2022
PMID: 35820461
Carl “Chip” Lavie, MD was senior author on an article published in The American Journal of Medicine recognizing the link between unhealthy lifestyle behaviors and the one million COVID-19 deaths in the United States.
Low-carbohydrate diets are effective at lowering blood sugar in unmedicated prediabetes and diabetes
Gabriel Uwaifo, MDJAMA Network Open - October 26, 2022
PMID: 36287562
A research team including Ochsner Endocrinologist Gabriel Uwaifo, MD, confirmed low-carb dietary interventions lead to blood sugar control improvement with prediabetic and diabetic individuals not taking blood sugar-lowering medication.
Addressing global disparities in blood pressure control: Ochsner Health physician lends perspective as member of the International Society of Hypertension
Jafar Alsaid, MDCardiovascular Research - October 11, 2022
PMID: 36219457
A recent study explored reasons behind global disparities in blood pressure control, noting that region-specific solutions are needed to address this worldwide health crisis.
The American Association of Clinical Endocrinology [AACE] Diabetes Mellitus Comprehensive Care Plan 2022 Update
Lawrence Blonde, MDEndocrine Practice - October 2022
PMID: 35963508
The 2022 AACE Diabetes Clinical Practice Guideline Update was developed by an AACE task force led by Lawrence Blonde, MD, FACP, MACE, Director of the Ochsner Diabetes Clinical Research Unit.
Read more
Monitoring of an aquatic pathogen’s genetic lineage cannot predict severe disease
Sonya Trinh, MDmBio - September 28, 2022
PMID: 36169197
A study of clinical isolates collected between 2011 and 2019 shows that severe disease outcomes related to vibrio vulnificus does not correlate with a specific genetic lineage.
Read more
Preserving Nasal Tip Rotation and Projection in Open Septorhinoplasty
Jason Pou, MDOchsner Journal - September 15, 2022
PMID: 36189084
An Ochsner Journal article by Jason Pou, MD, recommends a caudal septal extension graft for increasing nasal tip support in patients with insufficient caudal septal cartilage to repair severe septal deviations.
Read more
Ochsner pharmacist makes case for reducing use of broad-spectrum antibiotics for acute kidney infections
Kevin Lin, PharmDPLOS ONE - September 9, 2022
PMID: 36084051
A new study suggests that oral cephalosporins are as safe and effective as the standard of care fluoroquinolones (FQs) for the treatment of acute kidney infections.
Read more
Low Mortality of Orthopaedic Trauma Patients with Asymptomatic COVID-19: A level-1 Trauma Center Pandemic Experience
Patrick Massey, MDOchsner Journal - September, 2022
PMID: 36189099
Orthopedics research in early 2020 indicated that patients who were COVID-19–positive had alarming mortality and morbidity rates in the perioperative and postoperative periods, including increased pulmonary complications, thromboembolic events, sepsis, cardiac events, and death.
Read more
Study Utilizes Specialized Imaging and Molecular Profiling to Predict Complexity of Ovarian Cancer Surgery
Diogo Torres, MD
Gynocologic Oncology - September, 2022
PMID: 35931468
An observational pilot study to evaluate the effectiveness of molecular subtyping and imaging to predict disease resectability of the most common ovarian cancer histotype.
Read more
Endoscopic treatments can effectively control gastroesophageal reflux disease in appropriate patients
William Richardson, MD
Advances in Surgery - September, 2022
PMID: 36096568
A new study by Ochsner researchers that examined the efficacy of an endoscopic suturing device (TIF), radiofrequency device (Stretta) and a promising newer technique called antireflux mucosectomy.
Read more
Hospitalization risk among NVAF and COVID-19 patients undergoing apixaban treatment
Steven Deitelzweig, MD
Current Medical Research and Opinion - August 24, 2022
PMID: 36000258
A study to evaluate the risk of hospitalization among nonvalvular atrial fibrillation (NVAF) patients with an outpatient COVID-19 diagnosis undergoing apixaban treatment.
Read more
Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program
Eboni Price-Haywood, MD
JAMA Network Open - August 23, 2022
PMID: 35997977
A recent study published in JAMA Network Open explored differences in spending among Medicare Advantage (MA) and Medicare Shared Savings Program (MSSP) participants.
Read more
Collaboration uncovers what happens to genes inside artery plaques to trigger strokes
Hernan Bazan, MD
Scientific Reports - August 5, 2022
PMID: 35931792
Researchers at Ochsner Health and Tulane University School of Medicine have identified the genes that become active in carotid arteries when plaque rupture causes a stroke.
Read more
Early warning criteria are associated with increased odds of severe postpartum morbidity and mortality
Jane Martin, MD
American Journal of Obstetrics & Gynecology MFM - August 2, 2022
PMID: 35931369
Maternal-fetal medicine research at Ochsner has resulted in Maternal Early Warning Criteria (MEWC) being accepted by the National Partnership for Maternal Safety to identify obstetric patients at high risk for severe maternal morbidity and mortality.
Read more
Linking the Importance of Behavioral Counseling to Cardiovascular Risk Management
Carl J. Lavie, MD
Journal of the American Medical Association Cardiology - July 26, 2022
PMID: 35881408
An editorial that highlights the direct connection between behavioral modification through counseling to marked improvements in risk factors related to Cardiovascular Disease (CVD) and decreased mortality rates.
Read more
Ochsner study shows that social circumstances have outsized impact on hypertension control
Richard Milani, MD
Mayo Clinic Proceedings - July 19, 2022
PMID: 35868877
New research highlights the significant impact of social determinants of health on patients’ ability to sustain control of hypertension.
Read more
Developing an exosome-based liquid-biopsy signature for the noninvasive and robust detection of PDAC
John Bolton, MD
Gastroenterology - July 16, 2022
PMID: 35850192
The incidence of pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, is rising worldwide.
Read more
Making the case for expanded coverage of carotid artery stenting
Christopher White, MD
Journal of the American College of Cardiology - July 12, 2022
PMID: 35798450
Research from Ochsner Health is likely to influence expanded insurance coverage for carotid artery stenting.
Read more
Patients who live in low-access areas receive inadequate osteoporosis care after hip fracture
Sara Galli, MD
Journal of Clinical Densitometry - Jul-Sep 2022
PMID: 34696980
After many years of decline, the incidence of hip fractures caused by fragility has plateaued in the United States as rates of osteoporosis testing and treatment continue to decline.
Read more
Statins may improve outcomes for patients with renal cell carcinoma
Marc Matrana, MD
European Journal of Cancer - June 30, 2022
PMID: 35780525
Renal cell carcinoma (RCC), a type of kidney cancer, is one of the most frequently diagnosed cancers of the urinary tract, and its incidence is predicted to increase.
Read more
Incomplete response to liver-directed therapies lead to negative outcomes in transplant patients
Kelley Nuñez, PhD
Frontiers in Oncology - June 17, 2022
PMID: 35785174
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is the fourth leading cause of cancer-related death in the world.
Read more
The importance of clinical trial participation through the lens of Pulmonary/Critical Care
Derek J. Vonderhaar, MD
Journal of the American Medical Association - June 16, 2022
PMID: 35707974
A continuation of research featured in The Lancet in 2019, the randomized clinical trial investigated patient outcomes during emergency tracheal intubations.
Read more
Outcomes for STEMI patients with COVID-19 improved during the course of the pandemic
Rajan Patel, MD
Journal of the American College of Cardiology - June 7, 2022
PMID: 35390486
Early in the COVID-19 pandemic, researchers determined that a patient’s risk of heart attack, medically known as myocardial infarction, doubled in the seven days following their COVID diagnosis.
Read more
CHAP Trial determines treating high blood pressure during pregnancy is safe for both mother and developing baby
Sherri Longo, MD
New England Journal of Medicine - May 12, 2022
PMID: 35363951
A new study proves through a large clinical trial that treating high blood pressure—even mild cases—during pregnancy is safe and beneficial for both mother and developing baby.
Read more
Target to make immunotherapy for cancer safer, while more effective
Daniel Johnson, MD
Cancer Cell - May 9, 2022
PMID: 35537412
Immune checkpoint inhibitors have revolutionized the treatment of many cancers by using our body’s immune system to kill cancer. These treatments sometimes can cause our immune system to fight healthy tissue instead, resulting in side effects.
Read more
20 Ochsner researchers rank among the top 2% in their fields worldwide
Elsevier Digital Commons - October 19, 2021
The ranking, considered the most prestigious worldwide, measures academic achievement based on bibliometric information and includes more than 160,000 researchers from the more than 8 million scientists considered to be active around the globe.
Read more
